Amneal Pharmaceuticals, Inc. provided earnings guidance for the full year of 2022. For the year, the company expects net revenue to be between $2.15 billion to $2.25 billion.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.655 USD | -0.97% | -6.14% | +8.24% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.24% | 2.07B | |
+51.94% | 803B | |
-5.80% | 351B | |
+19.28% | 324B | |
+11.46% | 303B | |
+16.96% | 243B | |
+2.25% | 228B | |
+11.15% | 217B | |
+7.27% | 164B | |
-3.21% | 155B |
- Stock Market
- Equities
- AMRX Stock
- News Amneal Pharmaceuticals, Inc.
- Amneal Pharmaceuticals, Inc. Provides Earnings Guidance for the Full Year of 2022